Prophylactic DNA vaccine targeting Foxp3( ) regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model (Q46264331)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 November 2017

Language	Label	Description	Also known as
English	Prophylactic DNA vaccine targeting Foxp3( ) regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model	scientific article published on 9 November 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29124314

Prophylactic DNA vaccine targeting Foxp3( ) regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29124314

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Kayhan Azadmanesh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Shokrollah Elahi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Jamshid Hadjati

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Afshin Namdar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Reza Mirzaei

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Arash Memarnejadian

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Roobina Boghosian

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Hamid Reza Mirzaei

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Hamid Farajifard

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Mehdi Zavar

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Farshid Noorbakhsh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Abbas Rezaei

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

publication date

9 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/29124314

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

367-379

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Foxp3 programs the development and function of CD4 CD25 regulatory T cells

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Naturally arising Foxp3-expressing CD25 CD4 regulatory T cells in immunological tolerance to self and non-self

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Coordinated regulation of myeloid cells by tumours

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Inhibition of CD4( )25 T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

DNA vaccines against cancer: from genes to therapy.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

DNA vaccines against cancer come of age.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Development of novel DNA vaccine for VEGF in murine cancer model

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Improved Anti-Treg Vaccination Targeting Foxp3 Efficiently Decreases Regulatory T Cells in Mice

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Inducing Humoral Immune Responses Against Regulatory T Cells by Foxp3-Fc(IgG) Fusion Protein.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25( ) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Foxp3: a critical regulator of the development and function of regulatory T cells

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

FOXP3-specific immunity.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Selective depletion of Foxp3 regulatory T cells improves effective therapeutic vaccination against established melanoma

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Functional characterization of Foxp3-specific spontaneous immune responses.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Silencing of Foxp3 delays the growth of murine melanomas and modifies the tumor immunosuppressive environment

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma.

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Myeloid-derived suppressor cell role in tumor-related inflammation

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Epidemiology of invasive cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Gr-1 CD115 Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Vaccination against the Forkhead Family Transcription Factor Foxp3 Enhances Tumor Immunity

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2088-6

21 January 2018

Identifiers

10.1007/S00262-017-2088-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29124314 AND SRC:MED&resulttype=core&format=json

8 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46264331&oldid=2207764999"